All In MedTech

Device Trial Radar · NCT03195140

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes

Last checked: Nov 19, 2026Latest source record: Dec 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". Randomized with 103 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

103

Actual

Start

Aug 11, 2017

Primary completion

Feb 6, 2018

Study completion Feb 6, 2018

Sponsor

Lead sponsor
Tandem Diabetes Care, Inc.Public (TNDM)
Sponsor type
Industry
Collaborators
Jaeb Center for Health Research
First posted
Jun 22, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A 6-week crossover study will compare PLGS to SAP outcomes in adults and youth \> 6 years old with type 1 diabetes (T1D).

Conditions

  • Diabetes Mellitus, Type 1

Interventions

  • Predictive Low Glucose SuspendDevice

    Application of Predictive Low Glucose Suspend

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hypoglycemia < 70 mg/dLTime frame: 3 weeks

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford University

    Palo Alto, California

  • William Sansum Diabetes Center

    Santa Barbara, California

  • Barbara Davis Center

    Aurora, Colorado

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.